Office Based Addiction Treatment Training and Technical Assistance (OBAT TTA)

A Resource for Healthcare and Social Services Professionals

Medical Considerations for People with SUD and Addressing Polysubstance Use (APP Prescribers Additional MAT 16 Hours Training)

October 27, 2020
4:00 pm–6:00 pm ET

This training is part 3 of 8 for the training series that will provide APPs the additional 16 hours to meet the requirements to obtain a MAT Certificate

Register now

Virtual meeting

Via Zoom
Visit the meeting URL

Description

Advanced Practice Practitioners (APPs) must complete 24 hours of specialized training to obtain a waiver to prescribe buprenorphine—an eight-hour MAT waiver training course plus an additional 16 hours of training. Until now, the additional 16 hours has primarily been available through online, pre-recorded modules.

Boston Medical Center’s OBAT TTA is proud to announce a new no-cost, live training series that will provide APPs the additional 16 hours to meet these requirements. This training was developed by and for APPs.

The 2nd session in this series is titled "Medical Considerations for People with SB and Addressing Polysubstance Use." It i will be offered October 27th from 4pm-6pm ET. 

*CME credits are pending approval*

Intended audience

Nurse Practitioners, Certified Nurse Midwifes (CNM), Clinical Nurse Specialists (CNS), Certified Registered Nurse Anesthetists (CRNA), and Physician Assistants

Objectives

Sponsored by

Bureau of Substance Addiction Services (DPH/BSAS), Providers Clinical Support System (PCSS), and Boston Medical Center Office Based Addiction Treatment and Technical Assistance (BMC OBAT TTA). 

Register now